Together, the partners aim to enable seamless access to integrated multi–species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.
Diepenbeek and Izegem, Belgium, July 24th, 2025 – InnoSer, a preclinical contract research organization (CRO); Connected-Pathology, a CRO specialized in advanced digital histopathology; and Poulpharm, a CRO with expertise in microbiology and preclinical veterinary research, join forces to deliver integrated preclinical services tailored for both veterinary and human healthcare research.
This strategic partnership is designed to enhance the preclinical capabilities of each partner, including advanced drug development and histopathology services. By aligning their complementary strengths, InnoSer and Poulpharm, through Connected-Pathology, will provide seamless preclinical support by integrating multi-species expertise, advanced digital histopathology, and streamlined workflows, accelerating research timelines.
This strategic collaboration combines:
By working strategically together, the three partners aim to:
